ALK and ROS1 non-small-cell lung cancer: two molecular subgroups sensitive to targeted therapy

Rosell R, Karachaliou N, Wolf J, Ou SH

Journal: Lancet Respir Med. 2014 Dec;2(12):966-8. doi: 10.1016/S2213-2600(14)70259-0
Veröffentlichung: 2. Dezember 2014 (Epub: 19. November 2014)